Leerink Partnrs Has Positive Outlook of WBA Q2 Earnings

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Equities researchers at Leerink Partnrs boosted their Q2 2025 earnings estimates for shares of Walgreens Boots Alliance in a note issued to investors on Tuesday, December 17th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will post earnings per share of $0.49 for the quarter, up from their previous forecast of $0.47. The consensus estimate for Walgreens Boots Alliance’s current full-year earnings is $1.53 per share.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. During the same period in the previous year, the firm posted $0.67 EPS. The firm’s revenue was up 5.9% compared to the same quarter last year.

A number of other analysts also recently issued reports on WBA. JPMorgan Chase & Co. decreased their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Barclays upped their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Jefferies Financial Group lowered their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. Finally, Royal Bank of Canada dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research report on Wednesday, December 4th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $12.58.

Walgreens Boots Alliance Stock Down 1.3 %

Shares of NASDAQ:WBA traded down $0.13 during midday trading on Thursday, hitting $9.57. The stock had a trading volume of 2,452,863 shares, compared to its average volume of 18,143,385. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The business’s 50-day simple moving average is $9.33 and its 200-day simple moving average is $10.60. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $27.05. The company has a market cap of $8.27 billion, a P/E ratio of -0.96, a PEG ratio of 1.36 and a beta of 0.66.

Institutional Trading of Walgreens Boots Alliance

A number of large investors have recently added to or reduced their stakes in WBA. Blue Trust Inc. raised its holdings in Walgreens Boots Alliance by 87.0% during the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 1,081 shares during the period. TD Private Client Wealth LLC boosted its position in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 3,208 shares during the period. Sentry Investment Management LLC bought a new position in shares of Walgreens Boots Alliance during the third quarter valued at about $30,000. Eastern Bank purchased a new position in shares of Walgreens Boots Alliance in the third quarter worth about $33,000. Finally, Strategic Investment Solutions Inc. IL purchased a new stake in Walgreens Boots Alliance during the 2nd quarter valued at about $34,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.45%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s payout ratio is -9.99%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.